Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara (Manila Bulletin File Photo)
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara, who leads the TG-VES, said more vaccine manufacturers were expected to file their EUA application before the Food and Drug Administration (FDA).
“Two or three more,” she told the Manila Bulletin in a Viber message when asked on the number of vaccine developers that will apply for EUA of their COVID-19 vaccines.
She said while, they were expecting more applicants, “we might not have any EUA approvals this month.”
Guevara noted that it takes longer than one week for the FDA to process EUA applications.
DOST
DOST Secretary Fortunato “Boy” T. de la Peña and Undersecretary Rowena Cristina Guevara, chair of the Task Group on Vaccine Evaluation and Selection (TG-VES), cited Moderna’s filing of its EUA application before the Food and Drug Administration (FDA) on Monday, April 26.
“The more brands granted EUA by our FDA means we have more choices and bigger chances for vaccine availability,” de la Peña told the Manila Bulletin in a Viber message.
FDA Director General Eric Domingo announced that Moderna has filed its EUA application before the regulatory body on Monday, April 26.
“We have been expecting this for some time now,’ Guevara said.
Additional incentives maybe needed to attract more potential vaccine manufacturers – DOST mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
At least two local pharmaceutical companies could possibly produce their own coronavirus disease (COVID-19) vaccines by "end of 2022” under a fill-and-finish vaccine manufacturing arrangements, the Department of Science and Technology (DOST) said Thursday, April 15.
India achieved the landmark after the beginning of Covid-19 vaccination drive on January 16. According to a rough evaluation, all eligible India..|News Track